{"id":279,"date":"2007-12-01T18:58:13","date_gmt":"2007-12-01T18:58:13","guid":{"rendered":"https:\/\/wwwtest.pharmacy.wisc.edu\/faculty\/hong-research-group\/?p=279"},"modified":"2025-06-20T19:04:12","modified_gmt":"2025-06-20T19:04:12","slug":"nanocarriers-as-an-emerging-platform-for-cancer-therapy","status":"publish","type":"post","link":"https:\/\/pharmacy.wisc.edu\/faculty\/hong-research-group\/2007\/12\/01\/nanocarriers-as-an-emerging-platform-for-cancer-therapy\/","title":{"rendered":"Nanocarriers as an Emerging Platform for Cancer Therapy"},"content":{"rendered":"

Abstract<\/h2>\r\nNanotechnology has the potential to revolutionize cancer diagnosis and therapy. Advances in protein engineering and materials science have contributed to novel nanoscale targeting approaches that may bring new hope to cancer patients. Several therapeutic nanocarriers have been approved for clinical use. However, to date, there are only a few clinically approved nanocarriers that incorporate molecules to selectively bind and target cancer cells. This review examines some of the approved formulations and discusses the challenges in translating basic research to the clinic. We detail the arsenal of nanocarriers and molecules available for selective tumour targeting, and emphasize the challenges in cancer treatment.\r\n\r\n
\r\n\r\n

Cited by<\/h2>\r\nThis article is cited by 1744 publications\r\n
    \r\n \t
  1. \r\n
    Zhang, T., Li, N., Wang, R., Sun, Y., He, X., Lu, X., Chu, L., & Sun, K. (2023). Enhanced therapeutic efficacy of doxorubicin against multidrug-resistant breast cancer with reduced cardiotoxicity.\u00a0Drug delivery<\/i>,\u00a030<\/i>(1), 2189118.\u00a0https:\/\/doi.org\/10.1080\/10717544.2023.2189118<\/a><\/div><\/li>\r\n \t
  2. \r\n
    Kwantwi L. B. (2023). The dual and multifaceted role of relaxin-2 in cancer.\u00a0Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico<\/i>, 10.1007\/s12094-023-03146-0. Advance online publication.\u00a0https:\/\/doi.org\/10.1007\/s12094-023-03146-0<\/a><\/div><\/li>\r\n \t
  3. \r\n
    Haq Khan, Z. U., Khan, T. M., Khan, A., Shah, N. S., Muhammad, N., Tahir, K., Iqbal, J., Rahim, A., Khasim, S., Ahmad, I., Shabbir, K., Gul, N. S., & Wu, J. (2023). Brief review: Applications of nanocomposite in electrochemical sensor and drugs delivery.\u00a0Frontiers in chemistry<\/i>,\u00a011<\/i>, 1152217.\u00a0https:\/\/doi.org\/10.3389\/fchem.2023.1152217<\/a><\/div><\/li>\r\n \t
  4. \r\n
    Wang, Q., Atluri, K., Tiwari, A. K., & Babu, R. J. (2023). Exploring the Application of Micellar Drug Delivery Systems in Cancer Nanomedicine.\u00a0Pharmaceuticals (Basel, Switzerland)<\/i>,\u00a016<\/i>(3), 433.\u00a0https:\/\/doi.org\/10.3390\/ph16030433<\/a><\/div><\/li>\r\n \t
  5. \r\n
    Schr\u00f6der, M., Petrova, M., Dobrikov, G. M., Grancharov, G., Momekova, D., Petrov, P. D., & Ugrinova, I. (2023). Micellar Form of a Ferrocene-Containing Camphor Sulfonamide with Improved Aqueous Solubility and Tumor Curing Potential.\u00a0Pharmaceutics<\/i>,\u00a015<\/i>(3), 791.\u00a0https:\/\/doi.org\/10.3390\/pharmaceutics15030791<\/a><\/div><\/li>\r\n \t
  6. \r\n
    Verma, J., Warsame, C., Seenivasagam, R. K., Katiyar, N. K., Aleem, E., & Goel, S. (2023). Nanoparticle-mediated cancer cell therapy: basic science to clinical applications.\u00a0Cancer metastasis reviews<\/i>, 10.1007\/s10555-023-10086-2. Advance online publication.\u00a0https:\/\/doi.org\/10.1007\/s10555-023-10086-2<\/a><\/div><\/li>\r\n \t
  7. \r\n
    Mei, B., Lin, T. W., Sheridan, G. S., Evans, C. M., Sing, C. E., & Schweizer, K. S. (2023). How Segmental Dynamics and Mesh Confinement Determine the Selective Diffusivity of Molecules in Cross-Linked Dense Polymer Networks.\u00a0ACS central science<\/i>,\u00a09<\/i>(3), 508\u2013518.\u00a0https:\/\/doi.org\/10.1021\/acscentsci.2c01373<\/a><\/div><\/li>\r\n \t
  8. \r\n
    Ji, H., Lou, X., Jiao, J., Li, Y., Dai, K., & Jia, X. (2023). Preliminary Structural Characterization of Selenium Nanoparticle Composites Modified by\u00a0Astragalus<\/i>\u00a0Polysaccharide and the Cytotoxicity Mechanism on Liver Cancer Cells.\u00a0Molecules (Basel, Switzerland)<\/i>,\u00a028<\/i>(4), 1561.\u00a0https:\/\/doi.org\/10.3390\/molecules28041561<\/a><\/div><\/li>\r\n \t
  9. \r\n
    Gosty\u0144ska, A., Czerniel, J., Ku\u017ami\u0144ska, J., Brzozowski, J., Majchrzak-Celi\u0144ska, A., Krajka-Ku\u017aniak, V., & Stawny, M. (2023). Honokiol-Loaded Nanoemulsion for Glioblastoma Treatment: Statistical Optimization, Physicochemical Characterization, and an In Vitro Toxicity Assay.\u00a0Pharmaceutics<\/i>,\u00a015<\/i>(2), 448.\u00a0https:\/\/doi.org\/10.3390\/pharmaceutics15020448<\/a><\/div><\/li>\r\n \t
  10. \r\n
    Josowitz, A. D., Bindra, R. S., & Saltzman, W. M. (2022). Polymer nanocarriers for targeted local delivery of agents in treating brain tumors.\u00a0Nanotechnology<\/i>,\u00a034<\/i>(7), 10.1088\/1361-6528\/ac9683.\u00a0https:\/\/doi.org\/10.1088\/1361-6528\/ac9683<\/a><\/div><\/li>\r\n \t
  11. \r\n
    Albert, C., Bracaglia, L., Koide, A., DiRito, J., Lysyy, T., Harkins, L., Edwards, C., Richfield, O., Grundler, J., Zhou, K., Denbaum, E., Ketavarapu, G., Hattori, T., Perincheri, S., Langford, J., Feizi, A., Haakinson, D., Hosgood, S. A., Nicholson, M. L., Pober, J. S., \u2026 Tietjen, G. T. (2022). Monobody adapter for functional antibody display on nanoparticles for adaptable targeted delivery applications.\u00a0Nature communications<\/i>,\u00a013<\/i>(1), 5998.\u00a0https:\/\/doi.org\/10.1038\/s41467-022-33490-8<\/a><\/div><\/li>\r\n \t
  12. \r\n
    Fei, Y., Ma, Y., Zhang, H., Li, H., Feng, G., & Fang, J. (2022). Nanotechnology for research and treatment of the intestine.\u00a0Journal of nanobiotechnology<\/i>,\u00a020<\/i>(1), 430.\u00a0https:\/\/doi.org\/10.1186\/s12951-022-01517-3<\/a><\/div><\/li>\r\n \t
  13. \r\n
    Zhang, B., Zhang, Y., Dang, W., Xing, B., Yu, C., Guo, P., Pi, J., Deng, X., Qi, D., & Liu, Z. (2022). The anti-tumor and renoprotection study of E-[c(RGDfK)2]\/folic acid co-modified nanostructured lipid carrier loaded with doxorubicin hydrochloride\/salvianolic acid A.\u00a0Journal of nanobiotechnology<\/i>,\u00a020<\/i>(1), 425.\u00a0https:\/\/doi.org\/10.1186\/s12951-022-01628-x<\/a><\/div><\/li>\r\n \t
  14. \r\n
    Bozzer, S., Dal Bo, M., Grimaldi, M. C., Toffoli, G., & Macor, P. (2022). Nanocarriers as a Delivery Platform for Anticancer Treatment: Biological Limits and Perspectives in B-Cell Malignancies.\u00a0Pharmaceutics<\/i>,\u00a014<\/i>(9), 1965.\u00a0https:\/\/doi.org\/10.3390\/pharmaceutics14091965<\/a><\/div><\/li>\r\n \t
  15. \r\n
    Cao, M., Shi, E., Wang, H., Mao, L., Wu, Q., Li, X., Liang, Y., Yang, X., Wang, Y., & Li, C. (2022). Personalized Targeted Therapeutic Strategies against Oral Squamous Cell Carcinoma. An Evidence-Based Review of Literature.\u00a0International journal of nanomedicine<\/i>,\u00a017<\/i>, 4293\u20134306.\u00a0https:\/\/doi.org\/10.2147\/IJN.S377816<\/a><\/div><\/li>\r\n<\/ol>","protected":false},"excerpt":{"rendered":"Abstract Nanotechnology has the potential to revolutionize cancer diagnosis and therapy. Advances in protein engineering and materials science have contributed to novel nanoscale targeting approaches that may bring new hope to cancer patients. Several therapeutic …","protected":false},"author":7,"featured_media":277,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[4],"tags":[],"class_list":["post-279","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-publications"],"acf":[],"_links":{"self":[{"href":"https:\/\/pharmacy.wisc.edu\/faculty\/hong-research-group\/wp-json\/wp\/v2\/posts\/279","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharmacy.wisc.edu\/faculty\/hong-research-group\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharmacy.wisc.edu\/faculty\/hong-research-group\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharmacy.wisc.edu\/faculty\/hong-research-group\/wp-json\/wp\/v2\/users\/7"}],"replies":[{"embeddable":true,"href":"https:\/\/pharmacy.wisc.edu\/faculty\/hong-research-group\/wp-json\/wp\/v2\/comments?post=279"}],"version-history":[{"count":2,"href":"https:\/\/pharmacy.wisc.edu\/faculty\/hong-research-group\/wp-json\/wp\/v2\/posts\/279\/revisions"}],"predecessor-version":[{"id":288,"href":"https:\/\/pharmacy.wisc.edu\/faculty\/hong-research-group\/wp-json\/wp\/v2\/posts\/279\/revisions\/288"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/pharmacy.wisc.edu\/faculty\/hong-research-group\/wp-json\/wp\/v2\/media\/277"}],"wp:attachment":[{"href":"https:\/\/pharmacy.wisc.edu\/faculty\/hong-research-group\/wp-json\/wp\/v2\/media?parent=279"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharmacy.wisc.edu\/faculty\/hong-research-group\/wp-json\/wp\/v2\/categories?post=279"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharmacy.wisc.edu\/faculty\/hong-research-group\/wp-json\/wp\/v2\/tags?post=279"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}